Report of the Commission on Intellectual Property Rights, Innovation and Public Health: An industry perspective

Bulletin of the World Health Organization

Volumn 84, Issue 5, 2006, Pages 419-420

  Noehrenberg, Eric ^a  

^a International Federation of Pharmaceutical Manufacturers and Associations   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH POLICY; INNOVATION; INTELLECTUAL PROPERTY RIGHTS; PUBLIC HEALTH;

ACCESS TO INFORMATION; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; HUMAN RIGHTS; LAW; MEDICAL RESEARCH; MEDICINE; PATENT; PRACTICE GUIDELINE; PROTECTION; PUBLIC HEALTH; SHORT SURVEY; WORLD HEALTH ORGANIZATION;

DEVELOPING COUNTRIES; DIFFUSION OF INNOVATION; DRUG INDUSTRY; INTELLECTUAL PROPERTY; PUBLIC HEALTH; WORLD HEALTH ORGANIZATION;

EID: 33646483543     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.06.032417     Document Type: Short Survey

References (8)

1. Public health, innovation and intellectual property rights. Report of the Commission on Intellectual Property Rights, Innovation and Public Health. Geneva: World Health Organization; 2006.
2. Bale HE. Consumption and Trade in Off-Patented Medicines. Working Paper No.65 for the Commission on Macroeconomics and Health. New Delhi: Indian Council for Research on International Economic Relations; 2001. Available from: http://www.eldis.org/static/DOC2462.htm
3. Bate R, Tren R, Urbach J. Still Taxed to Death: An Analysis of Taxes and Tariffs on Medicines, Vaccines and Medical Devices. AEI-Brookings Joint Center for Regulatory Studies Related Publication 05-04 revised February 2006. Available from: http://www.aei-brookings.org/publications/abstract.php?pid=930
4. Laing R, Olcay M. Pharmaceutical Tariffs: What Is Their Effect on Prices, Protection of Local Industry and Revenue Generation? Prepared for: The Commission on Intellectual Property Rights, Innovation and Public Health, World Health Organization, Geneva, May 2005. Geneva: World Health Organization; 2005. Available from: http://www.who.int/intellectualproperty/studies/tariffs/en/ index.html
5. Combating Counterfeit Drugs: Building Effective International Collaboration, 16-18 February 2006 - Rome, Italy. Available from: http://www.who.int/medicines/counterfeit_conference/en/
6. The Pharmaceutical Innovation Platform: Sustaining Better Health for Patients Worldwide. Geneva: IFPMA; 2004. Available from: http://www.efpia.org/ 2_indust/PipnNv2004.pdf
7. Accelerating access initiative. GlaxoSmithKline. Available from: http://www.gsk.com/responsibility/cr_issues/dwc_accelerating_access.htm
8. Attaran A. How Do Patents And Economic Policies Affect Access To Essential Medicines In Developing Countries? Health Affairs 2004;23:55-166